This site is intended for health professionals only

Revalidation to cost almost £1bn


7 November 2012

Share this story:

Medical revalidation will cost close to £1bn per year, a Department of Health (DH) policy analysis has confirmed.

Despite costing £97m every year over a ten-year period, the DH review said it was “challenging” to place monetary values on the resulting benefits of the revalidation initiative.

It is claimed that the “large majority” of revalidation costs will result from ‘opportunity costs’ in terms of doctors’ time.

Medical revalidation will cost close to £1bn per year, a Department of Health (DH) policy analysis has confirmed.

Despite costing £97m every year over a ten-year period, the DH review said it was “challenging” to place monetary values on the resulting benefits of the revalidation initiative.

It is claimed that the “large majority” of revalidation costs will result from ‘opportunity costs’ in terms of doctors’ time.

The costs incurred by doctors undertaking appraisals are expected to be “significantly greater” than those associated with making revalidation decisions – which are hoped to be “relatively low” – as it requires a  “considerable undertaking” by doctors on an annual basis.
 
Overall, however, the analysis concluded that revalidation carries benefits that are shown to “outweigh the costs” involved.

“Revalidation is shown to be a proportionate and cost-effective means of delivering the policy objectives,” the DH review said.

The intended benefits of revalidation include: increased public trust and confidence in doctors; improved patient safety, outcomes and quality of care; a reduction in the costs of support for the minority of doctors whose medical practice is poor, through earlier identification of performance issues; and a reduction in malpractice and litigation costs.

“Quantifying the benefits of revalidation is challenging,” said the DH review.

“For example, while it is clear that public trust and confidence in doctors is an essential component of any health system, putting a monetary value on this is not possible.”

Despite not being able to quantify such benefits, the DH analysis ruled revalidation was a “cost-effective” means of delivering them.

Want news like this straight to your inbox?

Related news

Data NHS workforce
MPs vote against greater transparency for workforce data
MPs have voted against amending the Health and Care Bill to grant greater transparency around...
Services need more resources to support new NICE guidance for depression
New NICE draft guidance has recommended that GPs do not routinely offer patients with ‘less...